Skip to the page content
Your donations
Passes our checks

Ecog-Acrin Medical Research Foundation Inc

EIN 46-0745339 · Philadelphia, PA

Public records show a registered, tax-exempt organization in good standing.

LegitimacyPassesRegistration and standingFinancial healthFair53 out of 100GovernanceStrong95 out of 100Impact evidenceDescribes programsHow well its results are evidenced

What it says it does

THE PURPOSE OF ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC. IS TO FOSTER CLINICAL RESEARCH WITHIN THE PUBLIC, NON-PROFIT AND PRIVATE SECTORS FOR THE DETECTION, DIAGNOSIS, PREVENTION AND TREATMENT OF CANCER AND OTHER RELATED DISEASES, INCLUDING THROUGH DEVELOPING TECHNOLOGY TO PREDICT PROGNOSIS AND RESPONSES TO THERAPEUTIC INTERVENTION FOR PATIENTS WITH CANCER AND OTHER RELATED DISEASES, THAT WILL ULTIMATELY IMPROVE THE OUTCOMES FOR CANCER PATIENTS.

Income
$53.3 million
Spending
$53.5 million
Spent on programs
86%
Reserves
1.3 months of spending
Largest source of income
government grants, 81%
Employees
126
Highest pay
$318,111, executive di

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Financial health

Fair: 53 out of 100. Higher than 21% of charities in its peer group (diseases, $10m to $100m).

  • Reserves

    10 of 35

    Spendable reserves would cover 1.3 months of spending.

  • Debt

    5 of 20

    It owes 61% of what it owns.

  • Living within its means

    8 of 15

    Spending exceeded income by 0% of income.

  • Income trend

    15 of 15

    Income rose 1% on the year before.

  • Spending floor

    15 of 15

    86% of spending went to programs and raising each dollar of donations cost 0 cents.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Governance

Strong: 95 out of 100. Higher than 28% of charities in its peer group (diseases, $10m to $100m).

  • Independent board

    25 of 25

    7 of 7 voting board members are independent.

  • Conflict of interest policy

    15 of 15

    Has a written conflict of interest policy.

  • Whistleblower policy

    8 of 8

    Has a written whistleblower policy.

  • Record keeping policy

    7 of 7

    Has a written policy on keeping and destroying records.

  • Board minutes

    5 of 5

    Keeps minutes of board meetings.

  • Board sees the tax return

    10 of 10

    Gave the board a copy of this return before filing it.

  • Pay set independently

    0 of 5

    Reports no independent review process for its chief executive's pay.

  • Independent check of accounts

    15 of 15

    Its accounts were audited by an independent accountant.

  • No reported misuse

    10 of 10

    Reports no diversion of assets, excess benefits or loans to insiders.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Impact evidence

Describes programs. Its tax return describes what it does but we have found no measurable results in it.

Programs described in its return (5)
  1. $39.3 million spent. FEDERAL GRANTS THE ECOG-ACRIN MEDICAL RESEARCH FOUNDATION INC., THROUGH ITS FEDERAL FUNDING, BOTH DIRECT AND AS A SUBRECIPIENT, SUPPORTS THE EFFORTS OF THE NCI TO IMPROVE OUTCOMES FOR CANCER PATIENTS. THIS FEDERAL FUNDING AIDS ECOG- ACRIN IN PROVIDING THE SUPPORT NECESSARY TO CONDUCT RELEVANT AND RIGOROUS CLINICAL TRIALS, WHICH BENEFIT PUBLIC HEALTH BY IMPROVING THE QUANTITY AND STANDARD OF CARE FOR CANCER PATIENTS. IN ADDITION, THE FUNDS ARE USED TO PROMOTE COLLABORATION ACROSS A PROLIFIC SCIENTIFIC COMMUNITY AND TO CONTINUE THE STRONG ENGAGEMENT OF PATIENT ADVOCACY AT ALL LEVELS.
  2. $4.8 million spent. PHARMACEUTICAL GRANTS THROUGH SUPPLEMENTAL FUNDING ON NCI APPROVED AND FUNDED TRIALS, ECOG-ACRIN MEDICAL RESEARCH FOUNDATION INC. CARRIES OUT ACTIVITIES DESCRIBED IN THE SCOPE OF FUNCTIONS OF EACH NCI PROTOCOL. ALL FUNCTIONS ARE PERFORMED IN COMPLIANCE WITH FEDERAL, STATE AND LOCAL LAWS, WITH AN OVERARCHING GOAL OF REACHING FULL ACCRUALS TO FURTHER ADVANCE THE RESEARCH AND MEDICINE AIMED AT IMPROVING OUTCOMES FOR CANCER PATIENTS.
  3. $467,523 spent. FEDERAL CONTRACTS THE ECOG-ACRIN MEDICAL RESEARCH FOUNDATION INC., THROUGH ITS SUBRECIPIENT FEDERAL CONTRACT FUNDING FOR THE NCI MATCH AND MDS PROGRAMS AIDS ECOG-ACRIN IN PROVIDING THE SUPPORT NECESSARY TO CONDUCT SPECIFIC RELEVANT AND RIGOROUS CLINICAL TRIALS, WHICH AIM TO BENEFIT THE PUBLIC HEALTH BY IMPROVING THE QUANTITY AND STANDARD OF CARE FOR CANCER PATIENTS.
  4. $1.4 million spent. OTHER PROGRAM SERVICES INDUSTRY PAYMENTS THE ECOG-ACRIN MEDICAL RESEARCH FOUNDATION INC. ALSO RECEIVES FUNDING ON BEHALF OF OTHER NCI-FUNDED CANCER COOPERATIVE GROUPS IN SUPPORT OF EFFORTS TAKEN BY INDIVIDUAL SITES THAT ARE CREDITED AS ECOG-ACRIN INSTITUTIONS ALIGNED WITH THE MISSION TO IMPROVE THE OUTCOMES FOR CANCER PATIENTS. THIS AND OTHER FUNDING IS PRIMARILY PASS-THROUGH PAYMENTS FROM OTHER GROUPS AND IS PASSED ALONG TO THE ECOG-ACRIN CREDITED SITES. THESE FUNDS ARE USED BY INSTITUTIONS TO CONTINUE THEIR COLLECTIVE EFFORTS OF CONDUCTING RELEVANT AND RIGOROUS CLINICAL TRIALS, WHICH AIM TO BENEFIT PUBLIC HEALTH BY IMPROVING THE QUANTITY AND STANDARD OF CARE FOR CANCER PATIENTS.
  5. OTHER PROGRAM SERVICES INDUSTRY PAYMENTS THE ECOG-ACRIN MEDICAL RESEARCH FOUNDATION INC. ALSO RECEIVES FUNDING ON BEHALF OF OTHER NCI-FUNDED CANCER COOPERATIVE GROUPS IN SUPPORT OF EFFORTS TAKEN BY INDIVIDUAL SITES THAT ARE CREDITED AS ECOG-ACRIN INSTITUTIONS ALIGNED WITH THE MISSION TO IMPROVE THE OUTCOMES FOR CANCER PATIENTS. THIS AND OTHER FUNDING IS PRIMARILY PASS-THROUGH PAYMENTS FROM OTHER GROUPS AND IS PASSED ALONG TO THE ECOG-ACRIN CREDITED SITES. THESE FUNDS ARE USED BY INSTITUTIONS TO CONTINUE THEIR COLLECTIVE EFFORTS OF CONDUCTING RELEVANT AND RIGOROUS CLINICAL TRIALS, WHICH AIM TO BENEFIT PUBLIC HEALTH BY IMPROVING THE QUANTITY AND STANDARD OF CARE FOR CANCER PATIENTS.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Legitimacy checks

  1. Is it registered with the IRS? Passed.

    Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.

  2. Has the IRS revoked its tax-exempt status? Passed.

    Not on the IRS automatic revocation list.

    Source: Automatic revocation of exemption list, Internal Revenue Service, file dated September 30, 2026.

  3. Are donations tax-deductible? Passed.

    On the IRS list of organizations eligible to receive tax-deductible contributions.

    Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated September 10, 2026.

  4. Is it keeping up with its IRS filings? Passed.

    Most recent return on file covers the year ending December 2024.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.

  5. How long has it been tax-exempt? Passed.

    Recognized by the IRS since July 2013.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.

  6. Is it in good standing with state regulators? Passed.

    Not on California's list of charities barred from soliciting. Other states are not yet checked.

    Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 7, 2026.

Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.